Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-23 Purchase | 2025-06-25 4:30 pm | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer President & CEO | 6,146 | $1.1585 | $7,120 | 277,574 (Direct) | View |
| 2025-06-20 Purchase | 2025-06-24 4:30 pm | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer President & CEO | 10,000 | $1.2 | $12,000 | 271,428 (Direct) | View |
| 2025-06-17 Purchase | 2025-06-20 4:05 pm | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer President & CEO | 15,000 | $1.2 | $18,000 | 261,428 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-12 Option Award | 2025-06-16 5:00 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 20,000 | $1.23 | 246,428 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-16 5:00 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 25,000 | $1.19 | 246,428 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 20,000 | $1.27 | 201,428 (Direct) | View |
| 2025-03-06 Option Award | 2025-04-29 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 89,284 | $1.12 | 646,033 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Neal James R Director | 400,000 | $0 | 436,271 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Bazemore Robert B Director | 400,000 | $0 | 444,642 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 400,000 | $0 | 3,476,703 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 400,000 | $0 | 912,107 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 400,000 | $0 | 3,304,728 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner | 400,000 | $0 | 5,205,311 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Hombeck Torsten CFO | 500,000 | $0 | 500,200 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director | 1,700,000 | $0 | 1,881,428 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner | 1,785,714 | $1.12 | 6,591,025 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 892,856 | $1.12 | 3,797,584 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 812,500 | $1.12 | 3,889,203 (Indirect) | View |
| 2025-03-06 Option Award | 2025-03-10 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Neal James R Director | 8,928 | $1.12 | 45,199 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Bazemore Robert B Director | 89,284 | $1.12 | 133,926 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director | 267,856 | $1.12 | 449,284 (Direct) | View |
| 2025-01-10 Option Award(A) | 2025-02-07 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director | 11,640 | $1.22 | 47,500 (Direct) | View |
| 2025-01-10 Option Award | 2025-01-13 08:05 am | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director | 11,439 | $1.22 | 35,860 (Direct) | View |
| 2025-01-10 Option Award | 2025-01-13 08:05 am | N/A N/A | Akari Therapeutics Plc | AKTX | Hombeck Torsten CFO | 200 | $1.22 | 200 (Direct) | View |
| 2025-01-09 Option Award | 2025-01-10 5:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Neal James R Director | 8,000,000 | $0.0006 | 32,216,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director | 1,720,000 | $0.0006 | 71,720,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:30 pm | 2025-01-03 2035-01-03 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 152,672,000 | $0 | 5,493,579,500 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 208,000 | $0.0006 | 5,493,579,500 (Indirect) | View |
| 2024-12-26 Option Award | 2024-12-30 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 3,600,000 | $0.0005 | 5,340,699,500 (Indirect) | View |
| 2024-12-27 Option Award | 2024-12-30 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director | 40,000,000 | $0.0005 | 70,000,000 (Direct) | View |
| 2024-12-26 Option Award | 2024-12-27 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director | 30,000,000 | $0.0005 | 30,000,000 (Direct) | View |
| 2024-12-24 Option Award | 2024-12-27 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 7,500,000 | $0.0005 | 5,337,099,500 (Indirect) | View |
| 2024-12-23 Option Award | 2024-12-26 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Neal James R Director | 2,000,000 | $0.0005 | 24,216,000 (Direct) | View |
| 2024-12-23 Option Award | 2024-12-26 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 1,400,000 | $0.0005 | 5,329,599,500 (Indirect) | View |
| 2024-12-20 Option Award | 2024-12-26 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 1,400,000 | $0.0005 | 5,328,199,500 (Indirect) | View |
| 2024-11-30 Option Award | 2024-12-03 5:50 pm | 2024-11-30 2034-11-30 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 162,604,000 | $0 | 5,908,689,500 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-03 5:50 pm | 2024-12-02 2027-12-02 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 419,286,000 | $0.0012 | 5,908,689,500 (Indirect) | View |
| 2024-12-02 Option Award | 2024-12-03 5:48 pm | 2024-12-02 2027-12-02 | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 419,286,000 | $0.0012 | 5,335,886,800 (Direct) | View |
Ownership | 2024-11-22 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 0 | $0 | 1,259,014,000 (Direct) | View |
Ownership | 2024-11-22 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Neal James R Director | 0 | $0 | 335,286,000 (Direct) | View |
Ownership | 2024-11-22 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner | 0 | $0 | 8,632,790,000 (Direct) | View |